Subsequent ROC analyses revealed that UPP1 may function as an effective biomarker for identification of mesenchymal subtype glioma (Figure 1G,H), with the AUC of 92.1% in CGGA and 88.0% in TCGA. The gene discussed is UPP1; the disease is central nervous system cancer.